CC Exam Based Reference Study Guide

Wale DJ, Wong KK, Savas H, Kandathil A, Piert M, Brown RK. Extraosseous Findings on Bone Scintigraphy Using Fusion SPECT/CT and Correlative Imaging. AJR Am J Roentgenol. 2015 Jul;205(1):160-72. doi: 10.2214/AJR.14.13914. PMID: 26102395.

Tanguay A, Lebon J, Lau L, Hébert D, Bégin F. Detection of STEMI Using Prehospital Serial 12-Lead Electrocardiograms. Prehosp Emerg Care. 2018 Jul-Aug;22(4):419-426. doi: 10.1080/10903127.2017.1399185. Epub 2018 Jan 16. PMID: 29336652.

Bokhari S, Sheikh T. Cardiac sarcoidosis: Advantages and limitations of advanced cardiac imaging. J Nucl Cardiol. 2022 Oct;29(5):2145-2148. doi: 10.1007/s12350-021-02757-w. Epub 2021 Aug 23. PMID: 34426934.

Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Rosenbaum L, Shaw LJ, Stainback RF, Allen JM; American College of Cardiology Foundation Appropriate Use Criteria Task Force. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014 Feb 4;63(4):380-406. doi: 10.1016/j.jacc.2013.11.009. Epub 2013 Dec 16. PMID: 24355759.

Wright CL, Zhang J, Tweedle MF, Knopp MV, Hall NC. Theranostic Imaging of Yttrium-90. Biomed Res Int. 2015;2015:481279. doi: 10.1155/2015/481279. Epub 2015 May 28. PMID: 26106608; PMCID: PMC4464848

Schwaiger M, Brunken RC, Krivokapich J, Child JS, Tillisch JH, Phelps ME, Schelbert HR. Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J. 1987 Sep;8(9):981-8. doi: 10.1093/oxfordjournals.eurheartj.a062375. PMID: 3499320.

Alama M, Labos C, Emery H, Iwanochko RM, Freeman M, Husain M, Lee DS. Diagnostic and prognostic significance of transient ischemic dilation (TID) in myocardial perfusion imaging: A systematic review and meta-analysis. J Nucl Cardiol. 2018 Jun;25(3):724-737. doi: 10.1007/s12350-017-1040-7. Epub 2017 Sep 25. PMID: 28948540; PMCID: PMC5966496.

Weinrich JM, Lenz A, Adam G, François CJ, Bannas P. Radiologic Imaging in Large and Medium Vessel Vasculitis. Radiol Clin North Am. 2020 Jul;58(4):765-779. doi: 10.1016/j.rcl.2020.02.001. PMID: 32471543.

Ohira H, Tsujino I, Yoshinaga K. ¹8F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1773-83. doi: 10.1007/s00259-011-1832-y. Epub 2011 May 11. PMID: 21559980.

Ohira H, Tsujino I, Yoshinaga K. ¹8F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1773-83. doi: 10.1007/s00259-011-1832-y. Epub 2011 May 11. PMID: 21559980.

Sah BR, Husmann L, Mayer D, Scherrer A, Rancic Z, Puippe G, Weber R, Hasse B; VASGRA Cohort. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infections. Eur J Vasc Endovasc Surg. 2015 Apr;49(4):455-64. doi: 10.1016/j.ejvs.2014.12.024. Epub 2015 Jan 31. PMID: 25648371.

Sah BR, Husmann L, Mayer D, Scherrer A, Rancic Z, Puippe G, Weber R, Hasse B; VASGRA Cohort. Diagnostic performance of 18F-FDG-PET/CT in vascular graft infections. Eur J Vasc Endovasc Surg. 2015 Apr;49(4):455-64. doi: 10.1016/j.ejvs.2014.12.024. Epub 2015 Jan 31. PMID: 25648371.

Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22. PMID: 27143678.

Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017 Oct;24(5):1741-1758. doi: 10.1007/s12350-017-0978-9. PMID: 28770463.

Zerizer I, Tan K, Khan S, Barwick T, Marzola MC, Rubello D, Al-Nahhas A. Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol. 2010 Mar;73(3):504-9. doi: 10.1016/j.ejrad.2010.01.021. Epub 2010 Feb 20. PMID: 20172676.

Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, Forrester J, Janowitz W, Kaufmann PA, Mahmarian J, Moore SC, Stabin MG, Shreve P. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013 Aug;54(8):1485-507. doi: 10.2967/jnumed.112.105155. Epub 2013 Jun 18. PMID: 23781013.

Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Circ Cardiovasc Imaging. 2021 Jul;14(7):e000029. doi: 10.1161/HCI.0000000000000029. Epub 2021 Jul 1. PMID: 34196223.

Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4. PMID: 31480867; PMCID: PMC6736650.

Peterson LR, Gropler RJ. Radionuclide imaging of myocardial metabolism. Circ Cardiovasc Imaging. 2010 Mar;3(2):211-22. doi: 10.1161/CIRCIMAGING.109.860593. PMID: 20233863; PMCID: PMC2892800.

Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, Forrester J, Janowitz W, Kaufmann PA, Mahmarian J, Moore SC, Stabin MG, Shreve P. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013 Aug;54(8):1485-507. doi: 10.2967/jnumed.112.105155. Epub 2013 Jun 18. PMID: 23781013.

Slart RHJA, Glaudemans AWJM, Lancellotti P, Hyafil F, Blankstein R, Schwartz RG, Jaber WA, Russell R, Gimelli A, Rouzet F, Hacker M, Gheysens O, Plein S, Miller EJ, Dorbala S, Donal E; Document Reading Group. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. J Nucl Cardiol. 2018 Feb;25(1):298-319. doi: 10.1007/s12350-017-1043-4. PMID: 29043557.

Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. 2016 Jun;23(3):606-39. doi: 10.1007/s12350-015-0387-x. Erratum in: J Nucl Cardiol. 2016 Jun;23(3):640-2. PMID: 26914678.

https://www.baxterpi.com/pi-pdf/Regadenoson%20Injection%20PI%20Feb%202022%200719006306.pdf

ASNC Practice Points 99mTechnetium-Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis; https://www.asnc.org/?s=ASNC+Practice+Points+99mTechnetium-Pyrophosphate+Imaging+for+Transthyretin+Cardiac+Amyloidosis

Cavallaro G, Iorio O, Centanni M, Porta N, Iossa A, Gargano L, Del Duca S, Gurrado A, Testini M, Petrozza V, Silecchia G. Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: A Simple and Effective Way to Avoid Hypoparathyroidism. World J Surg. 2015 Aug;39(8):1936-42. doi: 10.1007/s00268-015-3070-0. PMID: 25862025.

Rachinger W, Stoecklein VM, Terpolilli NA, Haug AR, Ertl L, Pöschl J, Schüller U, Schichor C, Thon N, Tonn JC. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med. 2015 Mar;56(3):347-53. doi: 10.2967/jnumed.114.149120. Epub 2015 Jan 29. PMID: 25635133.

Judson BL, Shaha AR. Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism. J Nucl Med. 2008 Nov;49(11):1813-8. doi: 10.2967/jnumed.107.050237. Epub 2008 Oct 16. PMID: 18927330; PMCID: PMC3807731.

Hummel J, Wachsmann J, Carrick K, Oz OK, Mathews D, Peng F. Ectopic Thyroid Tissue in the Mediastinum Characterized by Histology and Functional Imaging with I-123 SPECT/CT. Case Rep Radiol. 2017;2017:9084207. doi: 10.1155/2017/9084207. Epub 2017 Jan 30. PMID: 28251012; PMCID: PMC5303849.

Mariani G, Tonacchera M, Grosso M, Orsolini F, Vitti P, Strauss HW. The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism. J Nucl Med. 2021 Mar;62(3):304-312. doi: 10.2967/jnumed.120.243170. Epub 2020 Oct 2. PMID: 33008929.

Mariani G, Tonacchera M, Grosso M, Orsolini F, Vitti P, Strauss HW. The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism. J Nucl Med. 2021 Mar;62(3):304-312. doi: 10.2967/jnumed.120.243170. Epub 2020 Oct 2. PMID: 33008929.

Matesan M, Bermo M, Cruite I, Shih CH, Elojeimy S, Behnia F, Lewis D, Vesselle H. Biliary Leak in the Postsurgical Abdomen: A Primer to HIDA Scan Interpretation. Semin Nucl Med. 2017 Nov;47(6):618-629. doi: 10.1053/j.semnuclmed.2017.06.002. Epub 2017 Jul 25. PMID: 28969760.

Bhattaru A, Pundyavana A, Raynor W, Chinta S, Werner TJ, Alavi A. 18F-FDG-PET and other imaging modalities in the diagnosis and management of inflammatory bowel disease. Am J Nucl Med Mol Imaging. 2024 Oct 15;14(5):295-305. doi: 10.62347/YXQT2560. PMID: 39583912; PMCID: PMC11578808.

Kwatra N, Shalaby-Rana E, Narayanan S, Mohan P, Ghelani S, Majd M. Phenobarbital-enhanced hepatobiliary scintigraphy in the diagnosis of biliary atresia: two decades of experience at a tertiary center. Pediatr Radiol. 2013 Oct;43(10):1365-75. doi: 10.1007/s00247-013-2704-3. Epub 2013 May 11. PMID: 23666168.

Holder LE. Radionuclide imaging in the evaluation of acute gastrointestinal bleeding. Radiographics. 2000 Jul-Aug;20(4):1153-9. doi: 10.1148/radiographics.20.4.g00jl351153. PMID: 10903704.

Grady E. Gastrointestinal Bleeding Scintigraphy in the Early 21st Century. J Nucl Med. 2016 Feb;57(2):252-9. doi: 10.2967/jnumed.115.157289. Epub 2015 Dec 17. PMID: 26678616.

Martins BC, Retes FA, Medrado BF, de Lima MS, Pennacchi CM, Kawaguti FS, Safatle-Ribeiro AV, Uemura RS, Maluf-Filho F. Endoscopic management and prevention of migrated esophageal stents. World J Gastrointest Endosc. 2014 Feb 16;6(2):49-54. doi: 10.4253/wjge.v6.i2.49. PMID: 24567792; PMCID: PMC3930890.

Majd M, Bar-Sever Z, Santos AI, De Palma D. The SNMMI and EANM Procedural Guidelines for Diuresis Renography in Infants and Children. J Nucl Med. 2018 Oct;59(10):1636-1640. doi: 10.2967/jnumed.118.215921. PMID: 30275286; PMCID: PMC6167528.  https://pubmed.ncbi.nlm.nih.gov/30275286/

Conway JJ, Maizels M. The “well-tempered” diuretic renogram: a standard method to examine the asymptomatic neonate with hydronephrosis or hydroureteronephrosis. A report from combined meetings of The Society for Fetal Urology and members of The Pediatric Nuclear Medicine Council–The Society of Nuclear Medicine. J Nucl Med. 1992 Nov;33(11):2047-51. PMID: 1432172.  https://pubmed.ncbi.nlm.nih.gov/1432172/

Rees JH, Sziklas JJ, Spencer RP, Chalasani G. Induced right-to-left cardiac shunt during pulmonary perfusion imaging. Clin Nucl Med. 1994 Nov;19(11):973-4. doi: 10.1097/00003072-199411000-00007. PMID: 7842591.

Stokland E, Hellström M, Jakobsson B, Sixt R. Imaging of renal scarring. Acta Paediatr Suppl. 1999 Nov;88(431):13-21. doi: 10.1111/j.1651-2227.1999.tb01314.x. PMID: 10588267.

Mettler, Fred A., Guiberteau, Milton J. 2006 Essential of nuclear medicine imaging 5th edition

Powsner RA, Edelstein RA, Jaffe T, Battinelli DL, Josephs LG. Diagnosis of postoperative urinary ascites using renal scintigraphy. Clin Nucl Med. 1997 Aug;22(8):523-5. doi: 10.1097/00003072-199708000-00002. PMID: 9262896.

Lim R. Vesicoureteral reflux and urinary tract infection: evolving practices and current controversies in pediatric imaging. AJR Am J Roentgenol. 2009 May;192(5):1197-208. doi: 10.2214/AJR.08.2187. PMID: 19380542.

Johnsen DE, Woodruff WW, Allen IS, Cera PJ, Funkhouser GR, Coleman LL. MR imaging of the sellar and juxtasellar regions. Radiographics. 1991 Sep;11(5):727-58. doi: 10.1148/radiographics.11.5.1947311. PMID: 1947311.

Toriihara A, Yamaga E, Nakadate M, Oyama J, Tateishi U. Detection of unexpected emergency diseases using FDG-PET/CT in oncology patients. Jpn J Radiol. 2017 Sep;35(9):539-545. doi: 10.1007/s11604-017-0664-5. Epub 2017 Jul 3. PMID: 28674772.

Minoshima S, Mosci K, Cross D, Thientunyakit T. Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer’s Disease and Other Types of Dementing Disorders. Semin Nucl Med. 2021 May;51(3):230-240. doi: 10.1053/j.semnuclmed.2021.01.002. Epub 2021 Feb 2. PMID: 33546814.

Essentials of Nuclear Medicine and Molecular Imaging Fred A. Metler. 7th edition. Chapter 3

Ponisio MR, Zempel JM, Day BK, Eisenman LN, Miller-Thomas MM, Smyth MD, Hogan RE. The Role of SPECT and PET in Epilepsy. AJR Am J Roentgenol. 2021 Mar;216(3):759-768. doi: 10.2214/AJR.20.23336. Epub 2021 Jan 21. PMID: 33474983.

Reddy M, Baugnon K. Imaging of Cerebrospinal Fluid Rhinorrhea and Otorrhea. Radiol Clin North Am. 2017 Jan;55(1):167-187. doi: 10.1016/j.rcl.2016.08.005. Review. PubMed PMID: 27890184.

NCCN Guidelines Version 2.2025 Invasive Breast Cancer, 3/5/25, https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. PMID: 30843003.

Koh MJ, Sadarangani SP, Chan YC, Chan MY, Tan AM, Tan SH, Tay YK, Ng SB. Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma). J Am Acad Dermatol. 2009 Nov;61(5):875-81. doi: 10.1016/j.jaad.2009.01.045. Epub 2009 Sep 9. PMID: 19744747.

Hung GD, Chen YH, Chen DY, Lan JL. Subcutaneous panniculitis-like T-cell lymphoma presenting with hemophagocytic lymphohistiocytosis and skin lesions with characteristic high-resolution ultrasonographic findings. Clin Rheumatol. 2007 May;26(5):775-8. doi: 10.1007/s10067-005-0193-y. Epub 2006 Feb 8. PMID: 16465478.

Kumbhar SS, Qi J. Normal FDG uptake in the adenoids and palatine tonsils in children on PET/MRI. Pediatr Radiol. 2020 Jun;50(7):958-965. doi: 10.1007/s00247-020-04650-z. Epub 2020 Mar 20. PMID: 32198664.

Okuyama C, Matsushima S, Nishimura M, Yamada K. Increased 18F-FDG accumulation in the tonsils after chemotherapy for pediatric lymphoma: a common physiological phenomenon. Ann Nucl Med. 2019 May;33(5):368-373. doi: 10.1007/s12149-019-01337-w. Epub 2019 Jan 28. PMID: 30689118.

Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110. doi: 10.1007/s00259-017-3690-8. Epub 2017 Apr 14. PMID: 28411336; PMCID: PMC5541086.

Sarri AJ, Tinois da Silva E, Vieira RADC, Koga KH, Cação PHM, Sarri VC, Moriguchi SM. Lymphoscintigraphy detecting alterations of upper limb lymphatic flow following early sentinel lymph node biopsy in breast cancer. Breast Cancer (Dove Med Press). 2017 Apr 19;9:279-285. doi: 10.2147/BCTT.S131407. PMID: 28458580; PMCID: PMC5402898.

https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast-Reaction-Card.pdf

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000627

Giammarile F, Chiti A, Lassmann M, Brans B, Flux G; EANM. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging. 2008 May;35(5):1039-47. doi: 10.1007/s00259-008-0715-3. PMID: 18274745.

Jadvar H, Calais J, Fanti S, Feng F, Greene KL, Gulley JL, Hofman M, Koontz BF, Lin DW, Morris MJ, Rowe SP, Royce TJ, Salami S, Savir-Baruch B, Srinivas S, Hope TA. Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging. J Nucl Med. 2022 Jan;63(1):59-68. doi: 10.2967/jnumed.121.263262. Epub 2021 Sep 30. PMID: 34593595; PMCID: PMC8717184.

EANM-SNMMI joint guidelines for 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy for tumour imaging

Nguyen NC, Tran I, Hueser CN, Oliver D, Farghaly HR, Osman MM. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study. Clin Nucl Med. 2009 Dec;34(12):886-90. doi: 10.1097/RLU.0b013e3181bece11. PMID: 20139823.

Yildirim H, Metintas M, Entok E, Ak G, Ak I, Dundar E, Erginel S. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study. J Thorac Oncol. 2009 Dec;4(12):1480-4. doi: 10.1097/JTO.0b013e3181c0a7ff. PMID: 19875971.

Kruse M, Sherry SJ, Paidpally V, Mercier G, Subramaniam RM. FDG PET/CT in the management of primary pleural tumors and pleural metastases. AJR Am J Roentgenol. 2013 Aug;201(2):W215-26. doi: 10.2214/AJR.13.10572. PMID: 23883236.

Kaghazchi F, Borja AJ, Hancin EC, Bhattaru A, Detchou DKE, Seraj SM, Rojulpote C, Hess S, Nardo L, Gabriel PE, Damrauer SM, Werner TJ, Alavi A, Revheim ME. Venous thromboembolism detected by FDG-PET/CT in cancer patients: a common, yet life-threatening observation. Am J Nucl Med Mol Imaging. 2021 Apr 15;11(2):99-106. PMID: 34079639; PMCID: PMC8165725.

Meissner VH, Gschwend JE, Heck MM. Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia’s Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup. Eur Urol. 2022 May;81(5):e117. doi: 10.1016/j.eururo.2022.01.039. Epub 2022 Feb 4. PMID: 35131117.

Kutaiba N, Ardalan Z, Patwala K, Lau E, Goodwin M, Gow P. Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant. Transplant Direct. 2018 Nov 23;4(12):e408. doi: 10.1097/TXD.0000000000000846. PMID: 30584589; PMCID: PMC6283090.

Wong DC. Malignant ascites visualized on a radionuclide bone scan. Australas Radiol. 1998 Aug;42(3):246-7. doi: 10.1111/j.1440-1673.1998.tb00507.x. PMID: 9727256.

Zwezerijnen GJC, Eertink JJ, Ferrández MC, Wiegers SE, Burggraaff CN, Lugtenburg PJ, Heymans MW, de Vet HCW, Zijlstra JM, Boellaard R. Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):486-493. doi: 10.1007/s00259-022-05977-5. Epub 2022 Sep 27. PMID: 36166080; PMCID: PMC9816285.

Cronin CG, Harisinghani MG, Catalano O, Blake MA. Multitechnique imaging findings of Prolene plug hernia repair. AJR Am J Roentgenol. 2010 Sep;195(3):701-6. doi: 10.2214/AJR.09.4142. PMID: 20729449.

Newman EA, Cimmino VM, Sabel MS, Diehl KM, Frey KA, Chang AE, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol. 2006 Jan;13(1):52-7. doi: 10.1245/ASO.2006.12.002. Epub 2006 Jan 1. PMID: 16372155.

Sood A, Youssef IM, Heiba SI, El-Zeftawy H, Axelrod D, Seigel B, Mills C, Abdel-Dayem HM. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004 Nov;29(11):698-702. doi: 10.1097/00003072-200411000-00005. PMID: 15483481.

Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med. 2003 Jul;33(3):205-18. doi: 10.1053/snuc.2003.127310. PMID: 12931322.

Abe Y, Tamura K, Sakata I, Ishida J, Mukai M, Ohtaki M, Nakamura M, Machida K. Unique intense uptake demonstrated by (18)F-FDG positron emission tomography/computed tomography in primary pancreatic lymphoma: A case report. Oncol Lett. 2010 Jul;1(4):605-607. doi: 10.3892/ol_00000107. Epub 2010 Jul 1. PMID: 22966351; PMCID: PMC3436258.

Goerres GW, Ziegler SI, Burger C, Berthold T, Von Schulthess GK, Buck A. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology. 2003 Feb;226(2):577-84. doi: 10.1148/radiol.2262012141. PMID: 12563158.

Kara PO, Kaya B, Gedik GK, Sari O, Varoglu E. Undescended testis in inguinal canal detected incidentally on fluorodeoxyglucose PET/CT imaging. Urology. 2012 Mar;79(3):e29-30. doi: 10.1016/j.urology.2011.10.057. Epub 2012 Jan 14. PMID: 22245311.

Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD; Imaging Subcommittee of International Harmonization Project in Lymphoma. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007 Feb 10;25(5):571-8. doi: 10.1200/JCO.2006.08.2305. Epub 2007 Jan 22. PMID: 17242397.

Yuan ST, Brown RK, Zhao L, ten Haken RK, Gross M, Cease KB, Schipper M, Stanton P, Yu J, Kong FM. Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy. Radiat Oncol. 2014 Jan 27;9(1):37. doi: 10.1186/1748-717X-9-37. PMID: 24467939; PMCID: PMC3996188.

Blake MA, McKernan M, Setty B, Fischman AJ, Mueller PR. Renal oncocytoma displaying intense activity on 18F-FDG PET. AJR Am J Roentgenol. 2006 Jan;186(1):269-70. doi: 10.2214/AJR.05.0110. PMID: 16357422.

Thoenes W, Störkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract. 1986 May;181(2):125-43. doi: 10.1016/S0344-0338(86)80001-2. PMID: 3737468.

Zukotynski K, Lewis A, O’Regan K, Jacene H, Sakellis C, Krajewski K, Israel D. PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology. AJR Am J Roentgenol. 2012 Aug;199(2):W163-7. doi: 10.2214/AJR.11.7790. PMID: 22826417.

Sheth S, Ali S, Fishman E. Imaging of renal lymphoma: patterns of disease with pathologic correlation. Radiographics. 2006 Jul-Aug;26(4):1151-68. doi: 10.1148/rg.264055125. PMID: 16844939.

Zukotynski K, Lewis A, O’Regan K, Jacene H, Sakellis C, Almodovar S, Israel D. PET/CT and renal pathology: a blind spot for radiologists? Part 2–lymphoma, leukemia, and metastatic disease. AJR Am J Roentgenol. 2012 Aug;199(2):W168-74. doi: 10.2214/AJR.11.7923. PMID: 22826418.

Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L. Diagnostic accuracy of ¹8F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumors: a systematic review and a meta-analysis. Skeletal Radiol. 2012 Mar;41(3):249-56. doi: 10.1007/s00256-011-1298-9. Epub 2011 Nov 10. PMID: 22072239.

McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol. 2005 Apr;184(4):1293-304. doi: 10.2214/ajr.184.4.01841293. PMID: 15788613.

Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI. Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg. 2000 Jun;35(6):961-4. doi: 10.1053/jpsu.2000.6936. PMID: 10873044.

Grant FD, Maclellan RA, Greene AK. (2014) , Lymphoscintigraphy. In: S. Ted Treves ed. Pediatric nuclear medicine and molecular imaging, 4th edition (pp. 189-202) Springer New York Heidelberg Dordrecht London.

Ziessman HA, O’Malley JP, Thrall JH. Nuclear Medicine: The Requisites, 4th Ed

Hain KS, Pickhardt PJ, Lubner MG, Menias CO, Bhalla S. Presacral masses: multimodality imaging of a multidisciplinary space. Radiographics. 2013 Jul-Aug;33(4):1145-67. doi: 10.1148/rg.334115171. PMID: 23842976.

Motz K, Qualliotine JR, Rettig E, Richmon JD, Eisele DW, Fakhry C. Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human Papillomavirus. JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):223-8. doi: 10.1001/jamaoto.2015.3228. PMID: 26769661.

Liu Y, Su L, Xiao H. Review of Factors Related to the Thyroid Cancer Epidemic. Int J Endocrinol. 2017;2017:5308635. doi: 10.1155/2017/5308635. Epub 2017 May 2. PMID: 28555155; PMCID: PMC5438865.

Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, Salizzoni E, Canini R, Cavo M, Fanti S. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging. 2006 May;33(5):525-31. doi: 10.1007/s00259-005-0004-3. Epub 2006 Feb 2. PMID: 16453155.

Estrada WN, Kim CK. Paget’s disease in a patient with breast cancer. J Nucl Med. 1993 Jul;34(7):1214-6. PMID: 8315505.

Federal Code of Regulations, Title 21 CFR 361.1

Ohnona J, Durand P, Amegnizin JL, Kerrou K. Silicone Granuloma in the Buttocks Incidentally Detected by 18F-FDG PET/CT 30 Years After Free Liquid Silicone Injections. Clin Nucl Med. 2016 Jun;41(6):492-3. doi: 10.1097/RLU.0000000000001206. PMID: 26975013.

Liu Y. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med. 2009 Feb;23(2):107-12. doi: 10.1007/s12149-008-0227-z. Epub 2009 Feb 19. PMID: 19225932.

Parise CA, Caggiano V. Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. J Cancer Epidemiol. 2014;2014:469251. doi: 10.1155/2014/469251. Epub 2014 May 26. PMID: 24955090; PMCID: PMC4058253.

Smith-Jones PM, Solit DB, Akhurst T, Afroze F, Rosen N, Larson SM. Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors. Nat Biotechnol. 2004 Jun;22(6):701-6. doi: 10.1038/nbt968. Epub 2004 May 9. PMID: 15133471.

Simsek DH, Sanli Y, Kuyumcu S, Basaran B, Mudun A. 68Ga-DOTATATE PET-CT imaging in carotid body paragangliomas. Ann Nucl Med. 2018 May;32(4):297-301. doi: 10.1007/s12149-018-1242-3. Epub 2018 Feb 21. PMID: 29468487.

Ravenel JG, Kipfmueller F, Schoepf UJ. CT angiography with multidetector-row CT for detection of acute pulmonary embolus. Semin Roentgenol. 2005 Jan;40(1):11-9. doi: 10.1053/j.ro.2004.09.012. PMID: 15732556.

Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O’Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR. Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors. J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12. PMID: 29025982; PMCID: PMC6910630.

Hofman MS, Lau WF, Hicks RJ. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics. 2015 Mar-Apr;35(2):500-16. doi: 10.1148/rg.352140164. PMID: 25763733.

Bartel TB, Kuruva M, Gnanasegaran G, Beheshti M, Cohen EJ, Weissman AF, Yarbrough TL. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol. 2018 Dec;46(4):398-404. PMID: 30518604.

Bartel TB, Kuruva M, Gnanasegaran G, Beheshti M, Cohen EJ, Weissman AF, Yarbrough TL. SNMMI Procedure Standard for Bone Scintigraphy 4.0. J Nucl Med Technol. 2018 Dec;46(4):398-404. PubMed PMID: 30518604.

Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM. The significance and management of incidental18F fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer. AJNR Am J Neuroradiology. 2009 Aug;30(7):1431-4. doi:10.3174/ajnr.A1559. Epub 2009 Apr 2. PubMed PMID: 19342543.

Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, Peller PJ, Bahn RS, Lowe VJ. Clinical significance of diffusely increased 18F-FDGuptake in the thyroid gland. J Nucl Med. 2007 Jun;48(6):896-901. Epub 2007 May15. PubMed PMID: 17504869.

Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin’s Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800. PMID: 25113753; PMCID: PMC4979083.

Montoriol PF, Boudinaud C. Ovarian metastases from ileal neuroendocrine tumour: Multimodality imaging. J Med Imaging Radiat Oncol. 2019 Jun;63(3):349-351. doi: 10.1111/1754-9485.12846. Epub 2018 Dec 26. PMID: 30585699.

Tripathy S, Naswa N, Jha P, Reddy S, Parida GK. Ileal Neuroendocrine Tumor
With Bilateral Breast and Ovarian Metastases: Findings on 68Ga-DOTANOC PET/CT
Scan. Clin Nucl Med. 2019 Sep;44(9):e532-e534. doi: 10.1097/RLU.0000000000002685.
PubMed PMID: 31274557.

Soman AD, Collins JM, DePetris G, Decker GA, Silva A, Moss A, Greer W, Ashman J, Callister M, Borad MJ. Isolated supraclavicular lymph node metastasis in pancreatic adenocarcinoma: a report of three cases and review of the literature. JOP. 2010 Nov 9;11(6):604-9. PMID: 21068495.

Lewis MA, Hobday TJ. Treatment of neuroendocrine tumor liver metastases. Int J Hepatol. 2012;2012:973946. doi: 10.1155/2012/973946. Epub 2012 Nov 25. PMID: 23227348; PMCID: PMC3512291.

Kumar M, Salem K, Jeffery JJ, Yan Y, Mahajan AM, Fowler AM. Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation. J Nucl Med. 2021 Apr;62(4):500-506. doi: 10.2967/jnumed.120.249508. Epub 2020 Aug 28. PMID: 32859700; PMCID: PMC8049365.

Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med. 2002 Mar;43(3):346-53. PMID: 11884494.

John B. Little, MD “Principal Cellular and Tissue Effects of Radiation,” in Cancer Medicine. 6th edition.

Penelope Allisy-Roberts, Jerry Williams, “Gamma Imaging” in Farr’s Physics for Medical Imaging (Second Edition), 2008

Sureshbabu W, Mawlawi O. PET/CT imaging artifacts. J Nucl Med Technol. 2005 Sep;33(3):156-61; quiz 163-4. PMID: 16145223.

Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, Jehanno N, Kurch L, Pandit-Taskar N, Parisi M, Piccardo A, Seghers V, Shulkin BL, Zucchetta P, Lim R. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0. J Nucl Med. 2021 Jan;62(1):99-110. doi: 10.2967/jnumed.120.254110. PMID: 33334912; PMCID: PMC8679588.

Gelfand MJ, O’hara SM, Curtwright LA, Maclean JR. Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients. Pediatr Radiol. 2005 Oct;35(10):984-90. doi: 10.1007/s00247-005-1505-8. Epub 2005 Jun 30. Erratum in: Pediatr Radiol. 2011 Apr;41(4):542. PMID: 15988582.

Söderlund V, Larsson SA, Jacobsson H. Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1018-22. doi: 10.1007/s00259-006-0318-9. Epub 2007 Jan 16. PMID: 17225118.

Parysow O, Mollerach AM, Jager V, Racioppi S, San Roman J, Gerbaudo VH. Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med. 2007 May;32(5):351-7. doi: 10.1097/01.rlu.0000259570.69163.04. PMID: 17452860.

George A, Sinha P, Conrad G, Memon AA, Dressler EV, Wagner LM. Pilot study of propranolol premedication to reduce FDG uptake in brown adipose tissue on PET scans of adolescent and young adult oncology patients. Pediatr Hematol Oncol. 2017 Apr;34(3):149-156. doi: 10.1080/08880018.2017.1338806. Epub 2017 Jul 20. PMID: 28727480; PMCID: PMC8075072.

Cousins J, Czachowski M, Muthukrishnan A, Currie G. Pediatric Brown Adipose Tissue on 18F-FDG PET: Diazepam Intervention. J Nucl Med Technol. 2017 Jun;45(2):82-86. doi: 10.2967/jnmt.116.187385. Epub 2017 Mar 9. PMID: 28280132.

Shammas A, Lim R, Charron M. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions. Radiographics. 2009 Sep-Oct;29(5):1467-86. doi: 10.1148/rg.295085247. PMID: 19755606.

Jadvar H, Connolly LP, Fahey FH, Shulkin BL. PET and PET/CT in pediatric oncology. Semin Nucl Med. 2007 Sep;37(5):316-31. doi: 10.1053/j.semnuclmed.2007.04.001. PMID: 17707239.

INTERNATIONAL ATOMIC ENERGY AGENCY, Nuclear Medicine Physics, Non-serial Publications , IAEA, Vienna (2015)

Robert J. Wilson. Collimator Technology and Advancements. Journal of Nuclear Medicine Technology Dec 1988, 16 (4) 198-203;

Kapoor V, McCook BM, Torok FS. An introduction to PET-CT imaging. Radiographics. 2004 Mar-Apr;24(2):523-43. doi: 10.1148/rg.242025724. PMID: 15026598.

Weber MF. Meeting Regulatory Needs. Health Phys. 2017 Feb;112(2):176-181. doi: 10.1097/HP.0000000000000620. PMID: 28027158.

Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction. Mol Imaging. 2018 Jan-Dec;17:1536012118811741. doi: 10.1177/1536012118811741. PMID: 31749411; PMCID: PMC6287320.

10 CFR 35.75 “Release of individuals containing unsealed byproduct material or implants containing byproduct material;” https://www.nrc.gov/reading-rm/doc-collections/cfr/part035/part035-0075.html

Reiners C, Schneider P. Radioiodine therapy of thyroid autonomy. Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S471-8. doi: 10.1007/s00259-002-0910-6. Epub 2002 Jul 18. PMID: 12192548.

Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, Tagawa ST, Nordquist LT, Vaishampayan N, El-Haddad G, Park CH, Beer TM, Armour A, Pérez-Contreras WJ, DeSilvio M, Kpamegan E, Gericke G, Messmann

RA, Morris MJ, Krause BJ; VISION Investigators. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23. PMID: 34161051; PMCID: PMC8446332.

Garje R, Hope TA, Rumble RB, Parikh RA; Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer Guideline Expert Panel. Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A. JCO Oncol Pract. 2023 Jan 24:OP2200753. doi: 10.1200/OP.22.00753. Epub ahead of print. PMID: 36693228.

Moore KN, Pothuri B. Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer: A Comprehensive Review. Cancer J. 2021 Nov-Dec 01;27(6):432-440. doi: 10.1097/PPO.0000000000000558. PMID: 34904806.

Kluetz PG, Pierce W, Maher VE, Zhang H, Tang S, Song P, Liu Q, Haber MT, Leutzinger EE, Al-Hakim A, Chen W, Palmby T, Alebachew E, Sridhara R, Ibrahim A, Justice R, Pazdur R. Radium ra 223 dichloride injection: u.s. Food and drug administration drug approval summary. Clin Cancer Res. 2014 Jan 1;20(1):9-14.doi: 10.1158/1078-0432.CCR-13-2665. Epub 2013 Nov 4. PubMed PMID: 24190979.

XOFIGO PRODUCT MONOGRAPH http://labeling.bayerhealthcare.com/html/products/pi/Xofigo_PI.pdf

Xofigo package insert

Lutetium  Lu 177 dotatate (Lutathera®) Prescribing Information (Advanced Accelerator Applications) 2018. https://www.adacap.com/wp-content/uploads/2018/01/Lutathera_lutetium_Lu_-177_dotatate_PI_2018_01.pdf

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O’Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. PMID: 28076709; PMCID: PMC5895095.

Xofigo package insert

Cremonesi M, Ferrari ME, Bodei L, Chiesa C, Sarnelli A, Garibaldi C, Pacilio M, Strigari L, Summers PE, Orecchia R, Grana CM, Botta F. Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning. Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2426-2441. doi: 10.1007/s00259-018-4044-x. Epub 2018 May 21. PMID: 29785514; PMCID: PMC6716520.

Rees JH, Sziklas JJ, Spencer RP, Chalasani G. Induced right-to-left cardiac shunt during pulmonary perfusion imaging. Clin Nucl Med. 1994 Nov;19(11):973-4. doi: 10.1097/00003072-199411000-00007. PMID: 7842591.

Nuclear Medicine and Molecular Imaging: The Requisites (Requisites in Radiology) 5th Edition by Janis P. O’Malley MD (Author), Harvey A. Ziessman MD (Author), James H. Thrall MD (Series Editor)

Mann A, DiDea M, Fournier F, Tempesta D, Williams J, LaFrance N. The Importance of Quality in Ventilation-Perfusion Imaging. J Nucl Med Technol. 2018 Jun;46(2):89-95. doi: 10.2967/jnmt.118.210948. Epub 2018 May 3. PMID: 29724800.

Slavin JD Jr, Sherigar RM, Spencer RP. Ventilation-perfusion “reverse mismatch” from aspirated medication. Clin Nucl Med. 1998 Oct;23(10):719-20. doi: 10.1097/00003072-199810000-00025. PMID: 9790061.

Wartski M, Zerbib E, Regnard JF, Hervé P. Reverse ventilation-perfusion mismatch in lung cancer suggests intrapulmonary functional shunting. J Nucl Med. 1998 Nov;39(11):1986-9. PMID: 9829595.

De Cicco C, Bellomi M, Bartolomei M, Carbone G, Pelosi G, Veronesi G, De Pas T, Spaggiari L, Paganelli G. Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography. Ann Thorac Surg. 2008 Dec;86(6):1769-72. doi: 10.1016/j.athoracsur.2008.08.033. PMID: 19021972.

Waxman AD, Bajc M, Brown M, Fahey FH, Freeman LM, Haramati LB, Julien P, Le Gal G, Neilly B, Rabin J, Soudry G, Tapson V, Torbati S, Kauffman J, Ahuja S, Donohoe K. Appropriate Use Criteria for Ventilation-Perfusion Imaging in Pulmonary Embolism: Summary and Excerpts. J Nucl Med. 2017 May;58(5):13N-15N. PMID: 28461589.

Cheon M, Yoo J. Metastatic Pulmonary Calcification Detected on 18F-FDG PET/CT and 99mTc-MDP Bone Scan. Diagnostics (Basel). 2021 Sep 6;11(9):1627. doi: 10.3390/diagnostics11091627. PMID: 34573968; PMCID: PMC8472040.

Nizami MA, Gerntholtz T, Swanepoel CR. The role of bone scanning in the detection of metastatic calcification: a case report. Clin Nucl Med. 2000 Jun;25(6):407-9. doi: 10.1097/00003072-200006000-00002. PMID: 10836684.

https://pubs.rsna.org/doi/epdf/10.1148/rg.232025103

Morag Y, Morag-Hezroni M, Jamadar DA, Ward BB, Jacobson JA, Zwetchkenbaum SR, Helman J. Bisphosphonate-related osteonecrosis of the jaw: a pictorial review.  Radiographics. 2009 Nov;29(7):1971-84. doi: 10.1148/rg.297095050.  PMID: 19926757.

Le BB, Nguyen BD. Ollier disease with digital enchondromatosis: anatomic and functional imaging. Clin Nucl Med. 2014 Aug;39(8):e375-8. doi: 10.1097/RLU.0000000000000284. PMID: 24152634.

Mitchell MD, Kundel HL, Steinberg ME, Kressel HY, Alavi A, Axel L. Avascular necrosis of the hip: comparison of MR, CT, and scintigraphy. AJR Am J Roentgenol. 1986 Jul;147(1):67-71. doi: 10.2214/ajr.147.1.67. PMID: 3487233.

Lyders EM, Whitlow CT, Baker MD, Morris PP. Imaging and treatment of sacral insufficiency fractures. AJNR Am J Neuroradiology. 2010 Feb;31(2):201-10. doi: 10.3174/ajnr.A1666. Epub 2009 Sep 17. PMID: 19762463; PMCID: PMC7964142.